1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine has been researched along with amoxapine in 3 studies
Studies (1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine) | Trials (1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine) | Recent Studies (post-2010) (1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine) | Studies (amoxapine) | Trials (amoxapine) | Recent Studies (post-2010) (amoxapine) |
---|---|---|---|---|---|
53 | 0 | 15 | 392 | 50 | 52 |
Protein | Taxonomy | 1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine (IC50) | amoxapine (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.0038 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 0.013 | |
Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 2.623 | |
Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 1.737 | |
Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.856 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 1.314 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 10 | |
Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 1.192 | |
D(2) dopamine receptor | Homo sapiens (human) | 0.2 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.558 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 3.174 | |
Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 1.781 | |
D(1A) dopamine receptor | Homo sapiens (human) | 0.392 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.013 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.306 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0016 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0038 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.034 | |
Histamine H1 receptor | Homo sapiens (human) | 0.099 | |
D(3) dopamine receptor | Homo sapiens (human) | 0.134 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.01 | |
5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.076 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hamblin, MW; Monsma, FJ; Shen, Y; Sibley, DR; Ward, RP | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
3 other study(ies) available for 1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine and amoxapine
Article | Year |
---|---|
Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding, Competitive; Blotting, Northern; Brain Chemistry; Cell Line; Cloning, Molecular; DNA; GTP-Binding Proteins; Lysergic Acid Diethylamide; Molecular Sequence Data; Polymerase Chain Reaction; Psychotropic Drugs; Rats; Receptors, Serotonin; RNA; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Transfection | 1993 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |